# Official evaluation acceptance checklist

Status is based on local validation and successful hosted GitHub Actions on Python 3.11 and 3.12. Publication verified on 2026-11-11.

| Criterion | Status | Evidence |
|---|---|---|
| Direct A/B Testing and Causal Inference topic | PASS | README title, randomized ITT experiment |
| Specific measurable question | PASS | No-show risk under assignment to 24-hour SMS |
| Hypothesis clearly defined | PASS | Two-sided H0 and H1; beneficial direction defined |
| Treatment/control justified | PASS | Standard process versus added SMS |
| Randomization documented | PASS | Independent Bernoulli 0.5 per unique patient |
| Target population identified | PASS | Eligible adult outpatient index appointments |
| One primary metric specified | PASS | ITT no-show rate |
| Appropriate guardrails evaluated | PASS | Cancellation, complaint, delivery, cost |
| Significance level documented | PASS | Alpha 0.05 |
| Power documented | PASS | 80% planning target |
| MDE documented | PASS | 3 pp absolute |
| Sample size calculated | PASS | 2,629 expected per arm, 5,258 total |
| Duration documented | PASS | 53-day enrollment + up to 31-day follow-up |
| Synthetic source and assumptions disclosed | PASS | README DGP and fixed seed |
| Data quality implemented | PASS | Fail-fast checks and reports |
| SRM evaluated | PASS | Pearson chi-square with expected 50/50 |
| Appropriate statistical analysis | PASS | Large-sample matched Wald test/CI; Wilson/Newcombe safety bounds |
| Both group results reported | PASS | README and analysis.json |
| Causal effect reported | PASS | Unadjusted ITT risk difference |
| 95% CI reported | PASS | README and analysis.json |
| P-value reported | PASS | Two-sided primary test |
| Significance interpreted correctly | PASS | No nonsignificance-as-no-effect claim |
| Business significance discussed | PASS | 2 pp point threshold and economic gates |
| Limitations explained | PASS | Internal/external validity and synthetic evidence |
| Evidence-based decision provided | PASS | All gates evaluated; synthetic Launch |
| Python scripts complete | PASS | main.py and modular src/ |
| requirements.txt included | PASS | Pinned direct dependencies |
| README complete | PASS | Generated report with actual outputs |
| Analytical outputs saved | PASS | CSV, JSON, Markdown and six PNGs |
| Python execution verified | PASS | Automated tests and full pipeline passed locally |
| GitHub repository public | PASS | GitHub metadata confirms public visibility; all 35 main-branch file hashes verified |
| Repository URL available | PASS | https://github.com/MuaiedAlsharef/healthcare-sms-ab-testing |
| Academy and official link acknowledged | PASS | README |

**Acceptance: 33 of 33 listed criteria satisfied.**

Publication commit: `38d030690f016095609cde7bdc4b103d66f17449`.
All 35 project files, including the dataset and six PNG charts, were compared against local Git blob hashes and matched exactly before this status-only update.

Hosted validation: [GitHub Actions run 43074731568](https://github.com/MuaiedAlsharef/healthcare-sms-ab-testing/actions/runs/43074731568). Both Python 3.11 and 3.12 jobs passed dependency installation, automated tests, full execution, numerical/README verification, deterministic artifact checks and artifact upload. The workflow also runs on subsequent commits; inspect the latest Actions result for the current branch head.

The repository is ready for academic submission. The data remains entirely synthetic; no real-world clinical effectiveness or deployment authorization is claimed.
